Articles

• Select this article
  • M T Barakat,
  • K Meeran,
  • and S R Bloom

  Neuroendocrine tumours.

  Endocr Relat Cancer 11 (1) 1-18, doi:10.1677/erc.0.0110001
  • Abstract
  • Full Text (PDF)
• Select this article
  • W W de Herder,
  • E P Krenning,
  • C H J Van Eijck,
  • and S W J Lamberts

  Considerations concerning a tailored, individualized therapeutic management of patients with (neuro)endocrine tumours of the gastrointestinal tract and pancreas.

  Endocr Relat Cancer 11 (1) 19-34, doi:10.1677/erc.0.0110019
  • Abstract
  • Full Text (PDF)
• Select this article
  • D M Robertson,
  • H G Burger,
  • and P J Fuller

  Inhibin/activin and ovarian cancer.

  Endocr Relat Cancer 11 (1) 35-49, doi:10.1677/erc.0.0110035
  • Abstract
  • Full Text (PDF)
• Select this article
  • D Melisi,
  • T Troiani,
  • V Damiano,
  • G Tortora,
  • and F Ciardiello

  Therapeutic integration of signal transduction targeting agents and conventional anti-cancer treatments.

  Endocr Relat Cancer 11 (1) 51-68, doi:10.1677/erc.0.0110051
  • Abstract
  • Full Text (PDF)
• Select this article
  • N Biglia,
  • E Defabiani,
  • R Ponzone,
  • L Mariani,
  • D Marenco,
  • and P Sismondi

  Management of risk of breast carcinoma in postmenopausal women.

  Endocr Relat Cancer 11 (1) 69-83, doi:10.1677/erc.0.0110069
  • Abstract
  • Full Text (PDF)
• Select this article
  • D M Barnes,
  • R R Millis,
  • C E Gillett,
  • K Ryder,
  • D Skilton,
  • I S Fentiman,
  • and R D Rubens

  The interaction of oestrogen receptor status and pathological features with adjuvant treatment in relation to survival in patients with operable breast cancer: a retrospective study of 2660 patients.

  Endocr Relat Cancer 11 (1) 85-96, doi:10.1677/erc.0.0110085
  • Abstract
  • Full Text (PDF)
• Select this article
  • M D Ringel and
  • P W Ladenson

  Controversies in the follow-up and management of well-differentiated thyroid cancer.

  Endocr Relat Cancer 11 (1) 97-116, doi:10.1677/erc.0.0110097
  • Abstract
  • Full Text (PDF)
• Select this article
  • S M Powell,
  • V Christiaens,
  • D Voulgaraki,
  • J Waxman,
  • F Claessens,
  • and C L Bevan

  Mechanisms of androgen receptor signalling via steroid receptor coactivator-1 in prostate.

  Endocr Relat Cancer 11 (1) 117-30, doi:10.1677/erc.0.0110117
  • Abstract
  • Full Text (PDF)
• Select this article
  • C Passler,
  • C Scheuba,
  • G Prager,
  • K Kaczirek,
  • K Kaserer,
  • G Zettinig,
  • and B Niederle

  Prognostic factors of papillary and follicular thyroid cancer: differences in an iodine-replete endemic goiter region.

  Endocr Relat Cancer 11 (1) 131-9, doi:10.1677/erc.0.0110131
  • Abstract
  • Full Text (PDF)
• Select this article
  • L Shao,
  • Q Huang,
  • M Luo,
  • and M Lai

  Detection of the differentially expressed gene IGF-binding protein-related protein-1 and analysis of its relationship to fasting glucose in Chinese colorectal cancer patients.

  Endocr Relat Cancer 11 (1) 141-8, doi:10.1677/erc.0.0110141
  • Abstract
  • Full Text (PDF)
• Select this article
  • R Fossmark,
  • T C Martinsen,
  • S H Torp,
  • S Kawase,
  • A K Sandvik,
  • and H L Waldum

  Spontaneous enterochromaffin-like cell carcinomas in cotton rats (Sigmodon hispidus) are prevented by a somatostatin analogue.

  Endocr Relat Cancer 11 (1) 149-60, doi:10.1677/erc.0.0110149
  • Abstract
  • Full Text (PDF)